DEFA14A: Nukkleus to Acquire Star, Shifts to Defense Sector

Sentiment:

Proxy Statement Supplement


Nukkleus Inc. announces the acquisition of 100% of Star, a related party, for $73.4 million, pivoting its business focus to the defense sector, subject to shareholder approval.

Capital raiseThe acquisition involves the issuance of 4,770,340 shares of common stock and warrants to purchase an additional 12,017,648 shares, which could be considered a form of equity financing for the acquisition.The Company issued 5,549,502 shares of common stock subsequent to September 30, 2025, including 3,095,000 shares pursuant to the 2025 Equity Plan, which represents a form of capital raise or compensation.The acquisition also includes $16,000,000 and $3,000,000 promissory notes, which are forms of debt financing.
Worse than expectedThe pro forma net loss for the year ended December 31, 2024, is a substantial $(164,656,937), indicating significant historical underperformance.While the pro forma net income for the nine months ended September 30, 2025, is positive at $68,230,611, it is primarily driven by non-operating fair value adjustments of liability-classified stock purchase warrants, rather than core business operations.The potential for Star Equity Holders to own over 100% of the company's common stock upon warrant exercise suggests extreme dilution for current shareholders.

Summary

  • Nukkleus Inc. is acquiring 100% of Star for a total preliminary consideration of $73,362,292.
  • The consideration includes $21 million in cash and promissory notes ($16 million 12-month note, $5 million cash, less prior advances), 4,770,340 shares of Nukkleus common stock, a five-year warrant to purchase 12,017,648 shares at $1.50 per share, $3 million in cash, and a 6-month promissory note for $3 million at 8% interest.
  • The acquisition is a related-party transaction, as Nukkleus's CEO and director, Mr. Shalom, is also a controlling shareholder, CEO, and director of Star.
  • Post-acquisition, Nukkleus's business will focus on the defense sector.
  • The closing of the transaction is subject to customary conditions, including approval by Nukkleus shareholders as required by Nasdaq listing rules.
  • Unaudited pro forma financial statements show a net income of $68,230,611 for the nine months ended September 30, 2025, and a net loss of $(164,656,937) for the year ended December 31, 2024.
  • The Star Equity Holders would initially hold 28.7% of Nukkleus's common stock, with the potential to hold 100.9% upon full exercise of the Star Warrant, indicating significant potential dilution.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the substantial pro forma net loss in 2024, the reliance on non-operating fair value changes for 2025 pro forma net income, the significant potential dilution from warrants, and the related-party nature of the acquisition. While the strategic pivot to defense could be positive, the financial implications and governance concerns outweigh it in the immediate context of this filing.

Positives

  • The acquisition of Star will pivot Nukkleus's business focus to the defense sector, potentially offering a new strategic direction.
  • Pro forma net income for the nine months ended September 30, 2025, is $68,230,611, resulting in a pro forma diluted EPS of $3.76 for that period.

Negatives

  • The acquisition is a related-party transaction, raising potential conflict of interest concerns.
  • Pro forma net loss for the year ended December 31, 2024, is substantial at $(164,656,937), with a diluted EPS of $(16.95).
  • The significant pro forma net income for the nine months ended September 30, 2025, is largely driven by a non-operating 'Change in fair value of liability classified stock purchase warrants' of $123,369,695, indicating a lack of sustainable operational profitability.
  • The Star Equity Holders could potentially hold 100.9% of the Company's outstanding common stock if the Star Warrant is fully exercised, indicating massive potential dilution for existing shareholders and a significant shift in control.
  • A $3,000,000 payment is due to Star if Nukkleus fails to perform or maintain its Nasdaq listing.

Risks

  • The allocation of the purchase price is preliminary and subject to material adjustments, which could impact future results of operations and financial position.
  • The unaudited pro forma financial information is not necessarily indicative of the combined financial position or results of operations that would have been realized or of future results.
  • Significant potential dilution from the Star Warrant, which could result in Star Equity Holders owning over 100% of the company's common stock.
  • The company's future financial performance is heavily influenced by non-cash fair value adjustments of liability-classified stock purchase warrants.
  • Failure to maintain Nasdaq listing could trigger a $3,000,000 payment obligation to Star.

Future Outlook

The Company's business will be focused on the defense sector following the closing of the Star acquisition. The pro forma financial information is preliminary and not necessarily indicative of future results, as final purchase price allocation and integration activities may materially impact financial performance.

Management Comments

  • In the opinion of management, all adjustments necessary to present fairly the unaudited pro forma condensed combined financial information have been made.

Industry Context

The acquisition of Star and the subsequent pivot to the defense sector represents a significant strategic shift for Nukkleus Inc. This move positions the company in a potentially high-growth, but also highly regulated and competitive, industry. The success of this pivot will depend on effective integration and leveraging Star's existing capabilities within the defense market.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Shareholder Approval RequirementThe closing of the Star acquisition is subject to customary closing conditions, including approval by the Company's shareholders as required under applicable Nasdaq listing rules.Upon shareholder voteEnsures shareholder oversight for a significant transaction, particularly given the related-party nature and potential dilution.

Related Party Transactions

  • The acquisition of Star is a related-party transaction, as Mr. Shalom, the Chief Executive Officer and a director of Nukkleus Inc., is also a controlling shareholder, Chief Executive Officer, and a director of Star.
  • The consideration for the acquisition includes a $4,500,000 note receivable from a related party, which is eliminated in the pro forma adjustments.
  • Star has short-term loans from related parties totaling $4,500,000.

Stakeholder Impact

  • Shareholders: Significant potential dilution from the Star Warrant (up to 100.9% of outstanding shares if exercised) could substantially reduce their ownership percentage and control. The related-party nature of the transaction may raise governance concerns.
  • Management: Mr. Shalom's dual role as CEO/Director of both Nukkleus and Star highlights a potential conflict of interest, requiring careful oversight.
  • Employees (of Star): Integration into Nukkleus and the new defense sector focus could bring changes to their roles and responsibilities.
  • Creditors: The issuance of promissory notes as part of the acquisition consideration adds to the company's debt obligations.

Next Steps

  • Seek shareholder approval for the Star Purchase Proposal, Warrant Shares Proposal, ELOC Issuance Proposal, and Preferred Stock Conversion Issuance Proposal.
  • Finalize the allocation of the purchase price for the Star acquisition, including the fair value of tangible and identifiable intangible assets acquired and liabilities assumed.
  • Integrate Star's operations into Nukkleus, focusing on the defense sector.

Key Dates

DateDescription
2024-12-15Company entered into the original Securities Purchase Agreement and Call Option with Star.
2025-02-11First amendment to the Securities Purchase Agreement.
2025-05-13Second amendment to the Securities Purchase Agreement.
2025-06-15Third amendment to the Securities Purchase Agreement.
2025-07-25Fourth amendment to the Securities Purchase Agreement.
2025-09-15Parties executed and delivered the Amended and Restated Securities Purchase Agreement with Star.
2025-09-30Unaudited pro forma condensed combined balance sheet date and end of nine months period for statement of operations.
2025-11-24Date of the original Definitive Proxy Statement filing.
2025-12-10Most recent practicable date used for closing stock price to value common stock consideration.
2025-12-11Date of this Proxy Statement Supplement.

Recommendation

sell

The filing reveals a highly dilutive acquisition of a related party, where the warrants issued could lead to Star Equity Holders owning over 100% of the company. While the strategic pivot to the defense sector is noted, the pro forma financials show a substantial net loss in the prior year and a current year net income heavily reliant on non-operating fair value adjustments of warrants, rather than sustainable operational performance. The significant goodwill recognized and the related-party nature of the transaction, combined with the extreme potential dilution, present substantial risks and governance concerns for existing shareholders, making a 'sell' recommendation appropriate.

Keywords

Nukkleus Inc., Star Acquisition, Defense Sector, SEC Filing, Pro Forma Financials, Related Party Transaction, Shareholder Approval, Dilution, Warrants, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.